These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15817918)

  • 1. Does metformin modify ovarian responsiveness during exogenous FSH ovulation induction in normogonadotrophic anovulation? A placebo-controlled double-blind assessment.
    van Santbrink EJ; Hohmann FP; Eijkemans MJ; Laven JS; Fauser BC
    Eur J Endocrinol; 2005 Apr; 152(4):611-7. PubMed ID: 15817918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone.
    Hoffman DI; Lobo RA; Campeau JD; Tsai HM; Holmberg EA; Ono T; Frederick JJ; Platt LD; diZerega GS
    J Clin Endocrinol Metab; 1985 May; 60(5):922-7. PubMed ID: 3920235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility.
    Balen AH; Mulders AG; Fauser BC; Schoot BC; Renier MA; Devroey P; Struijs MJ; Mannaerts BM
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6297-304. PubMed ID: 15579793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens.
    van Santbrink EJ; Fauser BC
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3597-602. PubMed ID: 9360513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination.
    Palomba S; Falbo A; Orio F; Manguso F; Russo T; Tolino A; Annamaria C; Dale B; Zullo F
    Hum Reprod; 2005 Oct; 20(10):2879-86. PubMed ID: 15958399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating immunoreactive and bioactive follicle stimulating hormone concentrations in anovulatory infertile women and during gonadotrophin induction of ovulation using a decremental dose regimen.
    van Dessel HJ; Schoot BC; Schipper I; Dahl KD; Fauser BC
    Hum Reprod; 1996 Mar; 11(3):478-85. PubMed ID: 8671250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of chances for success or complications in gonadotrophin ovulation induction in normogonadotrophic anovulatory infertility.
    Mulders AG; Eijkemans MJ; Imani B; Fauser BC
    Reprod Biomed Online; 2003 Sep; 7(2):170-8. PubMed ID: 14567885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
    Köninger A; Sauter L; Edimiris P; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
    Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome.
    Palomba S; Orio F; Falbo A; Manguso F; Russo T; Cascella T; Tolino A; Carmina E; Colao A; Zullo F
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4068-74. PubMed ID: 15840746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors related to successful ovulation induction in patients with WHO group II anovulatory infertility.
    Howles CM; Alam V; Tredway D; Homburg R; Warne DW
    Reprod Biomed Online; 2010 Feb; 20(2):182-90. PubMed ID: 20113956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovulatory follicle dysfunction in lactating dairy cows after treatment with Folltropin-V at the onset of luteolysis.
    Giordano JO; Edwards JL; Di Croce FA; Roper D; Rohrbach NR; Saxton AM; Schuenemann GM; Prado TM; Schrick FN
    Theriogenology; 2013 May; 79(8):1210-7. PubMed ID: 23534994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women and WHO group II anovulatory infertile patients.
    Balasch J; Fábregues F; Peñarrubia J; Creus M; Vidal R; Casamitjana R; Manau D; Vanrell JA
    J Assist Reprod Genet; 1998 Oct; 15(9):552-9. PubMed ID: 9822984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy predictors for metformin and clomiphene citrate treatment in anovulatory infertile patients with polycystic ovary syndrome.
    Palomba S; Falbo A; Orio F; Tolino A; Zullo F
    Fertil Steril; 2009 Jun; 91(6):2557-67. PubMed ID: 18440534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
    Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta-analysis.
    Mulders AG; Laven JS; Eijkemans MJ; Hughes EG; Fauser BC
    Hum Reprod Update; 2003; 9(5):429-49. PubMed ID: 14640376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization cycles: a randomized, double-blind, placebo-controlled trial.
    Lamb JD; Shen S; McCulloch C; Jalalian L; Cedars MI; Rosen MP
    Fertil Steril; 2011 Apr; 95(5):1655-60. PubMed ID: 21315341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.
    Fauser BC; Alper MM; Ledger W; Schoolcraft WB; Zandvliet A; Mannaerts BM;
    Reprod Biomed Online; 2010 Nov; 21(5):593-601. PubMed ID: 20843746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women.
    Raffone E; Rizzo P; Benedetto V
    Gynecol Endocrinol; 2010 Apr; 26(4):275-80. PubMed ID: 20222840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ovulation induction with pure FSH in anovulatory patients resistant to clomifene citrate].
    Kably-Ambe A; Reyes-Cuervo H; Barrón-Vallejo J
    Ginecol Obstet Mex; 1996 Jul; 64():293-6. PubMed ID: 8756188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.